Physician profile
Grant E Schaneman
NPI 1922058833
$3,600.38
in general payments reported to CMS, 2019-2025
9 companies · $667 in 2025
The $667 reported for 2025 was more than what 77% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,384 · 2020: $74.73 · 2021: $126 · 2022: $90.81 · 2023: $21.26 · 2024: $236 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $548 · Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $547.97 |
| Food and Beverage | $376.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,014.29 | 2019-2025 | Precision7, Dailies Total1, Precision 1 |
| Johnson & Johnson Vision Care, INC. | $1,001.30 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $218.16 | 2024-2025 | Xdemvy |
| Glaukos Corporation | $120.65 | 2021-2022 | |
| Carl Zeiss Meditec, INC. | $74.73 | 2020 | |
| Abb Con-Cise Optical Group LLC | $69.23 | 2019 | |
| Coopervision INC. | $64.74 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $21.65 | 2019 | |
| Bausch & Lomb Americas INC. | $15.63 | 2024 | Infuse |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grant Schaneman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.